Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for HIV-associated wasting.[1]
In December 2007, the U.S. District Court of Massachusetts - in a class-action lawsuit that involved Merck Serono and Serostim - fined Serono a total of $704 million in criminal and civil liabilities for enacting "illegal schemes to promote, market and sell its drug."[2]
External links
References
- Serostim® (somatropin) For Injection | Website For Patients Serostim^
- SERONO TO PAY $704 MILLION FOR THE ILLEGAL MARKETING OF AIDS DRUG Department of Justice, 17 October 2005, retrieved 23 June 2018^